Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Boron substituted deoxyribonucleosides as cytotoxic agents

I H Hall1, A Elkins, A Sood

  • 1Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill 27599-7360, USA.

Anticancer Research
|November 1, 1996
PubMed
Summary

New boronated nucleosides show promise as cancer treatments, effectively inhibiting cancer cell growth by targeting DNA synthesis pathways. These compounds offer a novel approach to chemotherapy by disrupting essential cellular processes in cancer cells.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Faculty Mentor Development Intervention on Mentees' Subjective Career Success.

The chronicle of mentoring & coaching·2026
Same author

Impact of Mentors on Overall Faculty Experience and Reason for Leaving.

The chronicle of mentoring & coaching·2026
Same author

Effectiveness of a Structured Curriculum-Based Developmental Network Intervention.

The chronicle of mentoring & coaching·2026
Same author

Cross-Cultural Communication in Mentoring: Impact on Individual Growth.

The chronicle of mentoring & coaching·2026
Same author

Machine learning for predicting climate change impacts on <i>Pseudopithomyces chartarum</i> spore counts: a risk indicator of facial eczema.

New Zealand veterinary journal·2025
Same author

Cardiac dysfunction in transfusion-dependent β-thalassaemia: Insights into apolipoprotein E genotypes and iron metrics in a north Indian cohort.

British journal of haematology·2025

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Development of novel cytotoxic agents is crucial for effective cancer therapy.
  • Boronated nucleosides and modified nucleotides represent a class of compounds with potential anticancer properties.
  • Understanding the mechanism of action is key to optimizing therapeutic efficacy.

Purpose of the Study:

  • To evaluate the cytotoxic activity of base-substituted boronated nucleosides and phosphate-modified nucleotides against cancer cells.
  • To investigate the mode of action of promising derivatives, particularly 2'deoxyriboadenosine-N7-cyanoborane.
  • To identify the specific cellular targets and biochemical pathways affected by these novel compounds.

Main Methods:

  • Cytotoxicity assays were performed on murine and human cancer cell lines (both single cell suspensions and solid tumors).

Related Experiment Videos

  • Detailed mode of action studies were conducted on Tmolt3 cells using 2'deoxyriboadenosine-N7-cyanoborane.
  • Enzyme activity assays measured the effects on PRPP-amido transferase, nucleoside kinases, DNA polymerase alpha, and dihydrofolate reductase.

    • Main Results:

    • The boronated nucleoside and nucleotide derivatives exhibited significant cytotoxic activity against cancer cells.
    • Activity was more pronounced against single cell suspensions compared to solid tumor growth.
    • 2'deoxyriboadenosine-N7-cyanoborane preferentially suppressed DNA synthesis by inhibiting the purine de novo pathway, specifically PRPP-amido transferase.

    Conclusions:

    • Base-substituted boronated nucleosides and phosphate-modified nucleotides are effective cytotoxic agents against cancer cells.
    • The primary mechanism involves the inhibition of the purine de novo synthesis pathway, crucial for DNA production.
    • These compounds represent a promising new class of anticancer drugs with a targeted mode of action.